Research and Markets: Global DNA Vaccine Pipeline Analysis

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/fghrt4/global_dna) has announced the addition of the "Global DNA Vaccine Pipeline Analysis" report to their offering.

The global market for DNA vaccines is currently recording significant growth rates owing to the lesser side effects, ease of development, lesser cost and continued development in biotechnology arena. At present, not even a single DNA vaccine has been approved for human beings. However, around 100 products are under clinical trial for treating diseases like HIV infection, cancer and other infectious diseases. With regards to animal health, there are three DNA vaccines which have been approved. The first vaccine against West Nile Virus to be used in horses was approved in 2005.

Global DNA Vaccine Pipeline Analysis gives a comprehensive insight on the various DNA Vaccines being developed for the treatment of multiple diseases. Research report covers all the DNA Vaccines being developed in various development phases. Each DNA Vaccine profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process.

This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the DNA vaccine market based upon development process. Following parameters for each DNA Vaccine profile in development phase are covered in Global DNA Vaccine Pipeline Analysis research report:

Breakup of DNA Vaccine Pipeline by Clinical Phase:

Key Topics Covered:

1. Global DNA Vaccine Market Overview

2. DNA Vaccine Development Phase: Research

3. DNA Vaccine Development Phase: Preclinical

Excerpt from:
Research and Markets: Global DNA Vaccine Pipeline Analysis